이 에피소드에 관해
The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance. The top-class speakers of the series include Kay Davies (Oxford), Kevin M. Esvelt (MIT), Caroline Gutjahr (TUM), Henry T. Greely (Stanford), Dirk Inzé (Gent), Greg Newby (Broad Institute), Kai P. Purnhagen (Bayreuth), Pamela C. Ronald (UC Davis) and Jörg Vogel (HIRI/Würzburg).
The lecture series is part of the CAS Research Focus "CRISPR/Cas" . The spokesperson of this Research Focus is Prof. Dr. Eckhard Wolf (LMU).
The lecture series is part of the CAS Research Focus "CRISPR/Cas" . The spokesperson of this Research Focus is Prof. Dr. Eckhard Wolf (LMU).
영어
미국
과거 에피소드 검색
Center for Advanced Studies (CAS) Research Focus CRISPR/Cas의 과거 에피소드를 검색하세요.
이 팟캐스트의 다른 에피소드
Panel discussion with Dr. Oana Dima, Prof. Dr. Caroline Gutjahr, and Prof. Dr. Kai P. Purnhagen | Moderation: Christoph von Eichhorn. The dicussion is the final event in the lecture series "Out of the Box: CRISPR/Cas".
The lecture series reflects on the consequences of the revolutionary gene editin…
The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance. The top-class speakers of the series include Kay Davies (Oxford), Kevin M. Esvelt (MIT), Caroline Gutjahr (TU…
Sickle cell disease is one of the most prevalent diseases worldwide. Even optimal conventional care has demonstrated inferiority compared to curative options such as hematopoietic stem cell transplantation. Gene editing promises an elegant alternative cure to all patients lacking a matched donor, p…
The evetn is part of the lecture series "Out of the Box: CRISPR/Cas". The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance.
Genome editing gives precise control of the type of genetic modification made to a cell. Hematopoietic stem cells have pharmacologic properties of durability and output that still remain untapped. Matthew Porteus and his group are using genome editing of hematopoietic stem cells to develop new clas…
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Center for Advanced Studies (CAS)에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.
